The Children’s Tumor Foundation

Healx is a Cambridge, United Kingdom-based biotechnology company that focuses on treating rare diseases. It leverages artificial intelligence and machine learning to accelerate drug discovery and repurposing, pairing computational insights with pharmacology expertise and patient engagement to match therapies to specific diseases. The company uses generative AI to identify new drug candidates and repurpose existing medications with known safety profiles, aiming to lower development risk and cost while addressing unmet needs of patients with rare diseases.